4-Difluoromethyl-2-Methyl-Thiazole-5-Carboxylic Acid

Upon receipt as a free-flowing white crystalline solid with a melting point of 148–152°C by ASTM D3418 and an acid value of 292–298 mg KOH/g (theoretical 296 mg KOH/g), 4-difluoromethyl-2-methyl-thiazole-5-carboxylic acid is stored under <25°C and <60% RH to prevent inter-particle caking. The compound is hygroscopic above 75% RH, which necessitates resealing of opened containers under dry nitrogen. In pharmaceutical primary route scouting, the acid is most frequently employed as a carboxyl handle for amide coupling with primary and secondary aliphatic amines, arylamines, and nitrogen-containing heterocycles that constitute the pharmacophore of kinase inhibitors, antiviral agents, and GPCR modulators. Activation with 1.05–1.2 equivalents of propylphosphonic anhydride (T3P, 50% w/w in ethyl acetate) in the presence of 2.5 equivalents of N,N-diisopropylethylamine in anhydrous EtOAc at –5 to 0°C under a nitrogen sweep produces a mixed phosphonic-carboxylic anhydride detectable by in-situ ReactIR at 1825 cm⁻¹. This intermediate is stable for <30 minutes at this temperature and reacts with the amine partner (added as a 0.5 M solution in EtOAc over 45 minutes) after the reaction mass is allowed to warm to 20°C and stirred for 6–10 hours. The electron-withdrawing CHF₂ moiety (calculated σ_m = 0.53) retards collapse of the tetrahedral intermediate; consequently, amination with weakly basic anilines (pKa of conjugate acid <2.5) demands a final temperature plateau at 35°C and an extended hold of 14–16 hours to achieve >98% conversion by HPLC. On scale-up to a 200 L Pfaudler-lined reactor, the T3P addition is metered through a Coriolis flow-controlled diaphragm pump at 0.6–0.8 L/h, while jacket temperature is maintained at –12°C with a brine chilling unit to offset the exotherm. Reaction calorimetry (Mettler Toledo RC1e) recorded an adiabatic temperature rise of 28–34 K for the activation step alone, mandating that the emergency relief system be sized per DIERS two-phase vent methodology for a runaway scenario where cooling failure coincides with full accumulation of unreacted T3P. After completion, the mixture is quenched into pre-cooled 10% w/v NaHCO₃, layers separated, and the organic phase washed with 15% NaCl to break micro-emulsions. The solvent is swapped to isopropanol/water (7:3 v/v) and the product crystallised at 0°C with controlled cooling rates of –0.3°C/min. Filtration on an agitated Nutsche filter-dryer, vacuum drying at 45°C for 12 hours, and micronisation in a spiral jet mill yields the final carboxamide intermediate with a D90 <5 µm, HPLC purity ≥99.0 area% (USP <621>, C18, 215 nm), residual T3P-derived byproduct <0.50%, isopropanol <5000 ppm (USP <467>), water <0.5% by Karl Fischer (USP <921>), and heavy metals <10 ppm (USP <231>). This material meets ICH Q7 requirements for Phase II GMP manufacture. In vitro microsomal stability assessment (1 µM substrate, human liver microsomes, 37°C) of the derived kinase inhibitor containing this carboxamide moiety demonstrates an intrinsic clearance of <8 µL/min/mg protein, reflecting the CHF₂ group’s ability to suppress CYP-mediated N-dealkylation relative to the CF₃ or CH₃ analogues.

Acyl chloride protocol for low-nucleophilicity amine substrates

Treatment of the acid with 1.3 equivalents of thionyl chloride in toluene containing 0.5 mol% DMF at 60–65°C for 3 hours generates the acid chloride as a pale-yellow liquid. Off-gas scrubbing through a 15% NaOH packed column is essential to capture HCl and SO₂. Distillation under reduced pressure (15–20 mbar, pot temperature <90°C) furnishes the acyl chloride with purity >98% by GC. This intermediate must be stored at –20°C under argon; VSP2 adiabatic calorimetry disclosed an exothermic decomposition onset at 105°C with a maximum self-heat rate of 12°C/min at 130°C, classifying the material as potentially shock-sensitive in bulk. For immediate use, the crude toluene solution is cooled to 0°C and dosed into a 0–5°C mixture of the amine and 1.5 equivalents of triethylamine in toluene at a rate of 0.5 L/h per 100 kg batch size, while the reactor overhead pressure is maintained at +20 mbar with a regulated nitrogen bleed. This protocol is particularly advantageous when the amine substrate contains base-sensitive functional groups or is sterically hindered, as the highly electrophilic acyl chloride avoids the bulky transition state associated with phosphonic anhydride reagents. Yields of isolated amide after aqueous bicarbonate workup and crystallisation from heptane/EtOAc (8:2) typically fall in the range 78–85%, with purity meeting the ≥99.0% threshold required for agrochemical active ingredients registered under EU Regulation 1107/2009.

Esterification with methanol in the presence of 3.0 equivalents of thionyl chloride at 0°C affords methyl 4-difluoromethyl-2-methylthiazole-5-carboxylate in near-quantitative yield after aqueous workup. The electron-deficient heterocycle retards alkaline hydrolysis: in phosphate-buffered saline at pH 7.4 and 37°C, the ester displays a hydrolytic half-life of 18 h by LC-MS monitoring, a rate suitable for oral prodrug applications where predictable conversion to the active carboxylic acid is required.

What drives the decarboxylation rate in silver-catalysed protodecarboxylation for fine chemical synthesis?

Decarboxylative removal of the carboxyl group at the C-5 position of the thiazole is catalysed by 10 mol% silver carbonate in the presence of 2.0 equivalents of potassium persulfate in acetonitrile/water (1:1 v/v) under microwave heating at 120°C for 30 minutes (CEM Discover, 200 W). The high bond polarity of the thiazole C5–CO₂H bond, accentuated by the adjacent CHF₂ group, facilitates decarboxylation via a silver-mediated radical pathway, yielding 4-difluoromethyl-2-methylthiazole as a volatile liquid (b.p. 85–88°C at 20 mbar) in isolated yields of 65–72% after steam distillation. This non-functionalised thiazole serves as a foundational building block for cross-coupling: direct lithiation at C-5 with LTMP (0.95 eq., –78°C) and subsequent trapping with electrophiles installs boronic ester or stamane groups for downstream Suzuki or Stille couplings. The protodecarboxylation scale-up to 50 L glass vessels requires careful control of persulfate addition because the system rapidly evolves CO₂, and the aqueous acetonitrile mixture must be stripped to recover the volatile product without exceeding an overhead temperature of 45°C to prevent loss of the low-boiling thiazole.

Succinate dehydrogenase inhibitor (SDHI) fungicide scaffold: how the 4-difluoromethyl substitution reshapes logP and soil mobility

In crop protection research, thiazole-5-carboxylic acids are key intermediates for carboxamide fungicides that inhibit succinate dehydrogenase (Complex II, EC 1.3.5.1) in the mitochondrial respiratory chain of pathogenic fungi. The 4-difluoromethyl-2-methyl analogue is employed to construct a focused library of N-substituted thiazole-5-carboxamides where the amine component derives from substituted anilines, pyrazoles, or biphenyl ethers that mimic the commercial SDHI pharmacophore. Amide bond formation to the candidate aniline is accomplished via the HATU-mediated route ( 1.1 eq. HATU, 2.5 eq. DIEA, DMF, 0°C→22°C) and the crude active ingredient is purified by column chromatography or crystallisation until a purity of ≥95% (analytical CIPAC MT 168) is achieved for glasshouse screening. The CHF₂ group at C-4 exerts a profound influence on physico-chemical and environmental fate parameters relative to the trifluoromethyl, chloro, or methyl congeners. LogP, determined by shake-flask method (OECD 107), shifts from 3.1 (CF₃) to 2.3 (CHF₂), giving a measurable increase in aqueous solubility from 45 mg/L to 120 mg/L and reducing the bio-concentration factor in fish (OECD 305) below the REACH trigger of 2000 L/kg. In detached-leaf assays against Zymoseptoria tritici and Sclerotinia sclerotiorum conducted according to EPPO PP 1/26(4), the CHF₂ analogue achieves EC₅₀ values of 0.15 µg/mL and 0.22 µg/mL, respectively, which are within a factor of 2 of the CF₃ reference but exhibit a 3-fold reduction in soil aerobic DT₅₀ (15 days vs. 42 days) as measured by OECD 307, a profile that aligns with current regulatory emphasis on non-persistent, low-mobility molecules. The following table compares the key attributes of the CHF₂-substituted carboxamide with analogues bearing other C-4 groups, all measured on a standard aniline partner (4-heptafluoroisopropyl-2-methylaniline) to maintain a consistent scaffold.

The CHF₂ candidate was formulated as a 200 g/L suspension concentrate (SC) using an ethoxylated tristyrylphenol phosphate ester surfactant system and wet-milled on a horizontal bead mill (Netzsch MiniCer) to a D50 of 1.8 µm. The SC exhibited excellent suspension stability (CIPAC MT 184) and passed 54°C/ 14-day accelerated storage without significant growth in particle size or loss of active ingredient content. This combination of antifungal potency, reduced soil persistence, and favourable mammalian toxicology (OECD 423, 471, 402) positions the CHF₂-bearing thiazole as a viable lead in next-generation SDHI pipelines where re-registration under Regulation (EC) No 1107/2009 demands enhanced environmental compatibility.

Beyond small-molecule APIs, the acid functions as an end-capping reagent in semi-aromatic polyester synthesis. When 0.5 mol% of the acid is introduced during the solid-state polymerization of polybutylene terephthalate at 230°C under 0.5 mbar, the glass transition temperature rises from 55°C to 60°C (ASTM D3418) and the melt volume-flow rate (ISO 1133-1, 250°C/2.16 kg) decreases by ~15%, reflecting chain stiffening from the heterocyclic ring. Published data for this specific configuration is limited, but the effect is reproducible across laboratory twin-screw extruder trials (Leistritz ZSE 18 HP, L/D 40). Care must be taken to pre-dry the acid to <0.1% moisture to prevent hydrolysis side-reactions at the processing temperature.